135
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

An Atypical Case of Exogeneous Endophthalmitis after Intravitreal Injection Presenting with Roth Spots

, MDORCID Icon, , MDORCID Icon, , MDORCID Icon & , MDORCID Icon
Pages 1061-1067 | Received 05 Dec 2021, Accepted 29 Mar 2022, Published online: 12 Apr 2022
 

ABSTRACT

Purpose

To report an atypical case of exogeneous endophthalmitis presenting with Roth spots.

Case

A 67-year-old man presented with decreased vision, mild pain, and discomfort in his left eye 12 days after an intravitreal aflibercept injection. Best-corrected visual acuity was 20/200, and there were +3 anterior chamber cells. On fundus examination, multiple intraretinal hemorrhages with a central white core resembling a Roth spot were observed. Intravitreal antibiotic injections were performed, and a vitreous sample was taken. Although post-intravitreal injection history was available, full systemic screening was planned to rule out endogenous endophthalmitis because of the presence of these Roth spots. Vitrectomy was performed and methicillin-sensitive coagulase-negative Staphylococcus was detected on culture.

Conclusion

Although the presence of Roth spots is an unexpected finding in post-injection endophthalmitis, it was nevertheless demonstrated in our case. For this reason, it should be kept in mind that Roth spots can be encountered in bacterial endophthalmitis.

Consent

Informed consent was obtained from the patient for this case report.

Disclosure statement

The authors report no conflicts of interest related to this report. Other relationships: Ö. Yanık, None; S. Demirel, Consultant fee, Honorarium for lecturing (Novartis, Bayer, Allergan, Alcon, Baush & Lomb); F. Batıoğlu, Consultant fee, Honorarium for lecturing (Novartis, Bayer, Allergan, Thea); E. Özmert, Consultant fee, Honorarium for lecturing (Novartis, Bayer, Allergan).

Additional information

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.